Sandoz chief executive Richard Saynor has taken a further leadership position at the top of the off-patent industry after being named as the chair of the International Generic and Biosimilar Medicines Association’s CEO advisory committee.
Sandoz’s Saynor Leads IGBA’s CEO Advisory Committee
Chief Executive Chairs Panel As Lupin CEO Vinita Gupta Is Named Vice-Chair
Sandoz chief executive Richard Saynor has been named as chair of the IGBA’s CEO advisory committee, which was first convened earlier this year. At the same time, Lupin CEO Vinita Gupta has been made vice-chair.
